FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
We have now added a new section called the "Assay History List" to the "At A Gla...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...